To overcome this issue, we engineered CAR T cells redirected against ovarian cancer cells through the FSH hormone, the natural ligand of FSHR, expressed in ~60% of ovarian carcinomas of different histological subtypes [74]. Here, FSHR is linked to ovarian carcinoma.